Vietnam Chapter – Chambers Global Practice Guide: Healthcare M&A 2026

Kinstellar Southeast Asia has contributed the Vietnam chapter to the Chambers Global Practice Guides: Healthcare M&A 2026, authored by Minh Duong, Justin Gisz and Phong Nguyen.

Vietnam's healthcare M&A market is entering a new phase, with investors moving beyond digital health to focus on scalable healthcare platforms, diagnostics networks, pharmaceutical manufacturing and specialised care providers. This is reflected in notable transactions over the past 18 months, including Ares Management's investment in MEDLATEC, Quadria Capital's acquisition of Tam Tri Medical, and Livzon Pharmaceutical's tender offer for Imexpharm. At the same time, regulatory developments across Vietnam's pharmaceutical framework and foreign investment procedures are reshaping the deal landscape.

The chapter examines:

• Key healthcare M&A trends and investment activity
• Regulatory developments affecting healthcare transactions
• Foreign investment considerations
• Competition, licensing and operational issues in healthcare deals
• Data privacy and healthcare due diligence considerations

Click to view the full article.